PRKAA1 and cancer: PRKAA1, a subunit of the AMPK pathway, is critical to cellular activity and cancer development, and studies have demonstrated its role in cell differentiation, apoptosis, autophagy, and cancer progression [27–30] as well as in clinical prognosis [31, 32].